AET and generics. Active collaboration for pharmaceutical innovation.
In addition to offering an extensive portfolio of in-house developed generic drug products across indications, AET has started the development of biosimilars and innovative product designs. AET provides a comprehensive service from project concept (including global portfolio and IP strategy and competitive product design) via product development and registration through to production, timely delivery and the management of a competitive and reliable supply chain.
What we offer our clients
- Actively sourcing/developing non infringing FDF (finished dosage form)
- Investigating and advising on intellectual property
- Own R&D; Sourcing APIs, Technologies and Know how world wide
- A leading European supplier and service company for the generics industry
- Auditing all links in the supply chain
- Providing technical and regulatory service, resulting in your own marketing authorisation
- Serving as full logistics provider and delivering client brand FDF straight to your warehouse
- Ensuring day one launch of FDFs
- Highly flexible solution provider for generic portfolio building – wherever in the world
- Bringing High Quality Generics to the markets you choose
- Extensive track record for the development of state of the art generic drugs – the ethical company among the Generics
- Strong international growth (USA, LatAm, APAC, Africa, MENA, CIS … and the EU)